1.
Hamdard Medicus. 2009; 52 (1): 65-72
em Inglês
| IMEMR
| ID: emr-111554
RESUMO
Even after nearly 100 years of research, diabetes is the fourth leading killer disease in the developed world. Over 200 million diabetics live worldwide, accounting for huge economic and social burden. Thus the development of new effective therapeutic agents is the major thrust for research and is germane in both the national and international scenario. In India, diabetes is projected to three-fold increase, from 19.4 million in 1995 to 57.2 million in 2025. Here is a review on some of the recent medicinally active agents used against diabetes mellitus
Assuntos
Tiazolidinedionas/química , Hipoglicemiantes , Resistência à Insulina
2.
Hamdard Medicus. 2002; 45 (3): 27-38
em Inglês
| IMEMR
| ID: emr-59384
3.
Hamdard Medicus. 2001; 44 (2): 38-47
em Inglês
| IMEMR
| ID: emr-56870